Cannabis and Cannabinoids in Psychiatry: Risks and Benefits.

Am J Psychiatry

Child and Adolescent Psychiatry, Michigan Medicine, University of Michigan Health System, Ann Arbor, Mich.

Published: November 2022

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.20220233DOI Listing

Publication Analysis

Top Keywords

cannabis cannabinoids
4
cannabinoids psychiatry
4
psychiatry risks
4
risks benefits
4
cannabis
1
psychiatry
1
risks
1
benefits
1

Similar Publications

Cannabidiol (CBD) and Δ-tetrahydrocannabinol (THC), the main components of Cannabis sativa plants, can interact with specific cell receptors known as cannabinoid receptors (CBs). The endogenous compounds anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are CB agonists, and, alongside enzymes, they constitute the endocannabinoid system (ECS) and take part in neuromodulation. Several LC-MS/MS methods have been developed to quantify these compounds in biological matrixes, but a fast and simple method that can determine these analytes in plasma samples simultaneously is not available.

View Article and Find Full Text PDF

Cannabis trichome development progresses in distinct phases that underpin the dynamic biosynthesis of cannabinoids and terpenes. This study investigates the molecular mechanisms underlying cannabinoid and terpenoid biosynthesis in glandular trichomes of Cannabis sativa (CsGTs) throughout their development. Female Cannabis sativa c.

View Article and Find Full Text PDF

Regarding Ogunsola et al.

Cannabis Cannabinoid Res

January 2025

Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

View Article and Find Full Text PDF

: Cannabinoid Hyperemesis Syndrome (CHS), associated with long-term cannabinoid use, has been increasingly observed in emergency room visits as more states in the U.S. have legislatively permitted medical and recreational marijuana use.

View Article and Find Full Text PDF

This narrative review explores the benefits and risks of cannabinoids in kidney health, particularly in individuals with pre-existing renal conditions. It discusses the roles of cannabinoid receptor ligands (phytocannabinoids, synthetic cannabinoids, and endocannabinoids) in kidney physiology. The metabolism and excretion of these substances are also highlighted, with partial elimination occurring via the kidneys.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!